小胶质细胞在脊髓背角吞噬抑制性突触并调节小鼠骨癌痛行为
该研究在小鼠骨癌痛模型中探索小胶质细胞是否吞噬脊髓背角抑制性突触及其机制。结果显示骨癌痛小鼠出现持续自发痛和机械痛敏,小胶质细胞增殖并吞噬Gephyrin阳性抑制性突触,CD47-SIRPα信号下调;米诺环素或S-氯胺酮可缓解疼痛并抑制吞噬。
要点
- 骨癌痛小鼠脊髓背角小胶质细胞增殖并吞噬抑制性突触。
- CD47-SIRPα「别吃我」信号下调可能参与该吞噬过程。
- 米诺环素或S-氯胺酮可减轻疼痛并抑制突触吞噬。
核心结论
- 小胶质细胞介导脊髓背角GABA能突触修剪,可能与CD47-SIRPα信号下降有关,是骨癌痛的新机制。
研究设计与样本
- 雄性C3H/HeN小鼠诱导骨癌痛模型,D14注射米诺环素或S-氯胺酮。
- 在D0、D4、D7、D10、D14、D21、D28测量自发缩足次数和机械缩足阈值。
- 采用HE染色、Western blotting、流式细胞术、免疫荧光和三维重建检测。
主要发现
- 肿瘤细胞植入小鼠出现持续自发痛和机械痛敏,HE染色显示骨破坏和骨髓腔肿瘤浸润。
- 小胶质细胞发生反应性增殖(t = -16.831,P < .001)。
- 肿瘤组Gephyrin表达降低(D4、D7、D10、D14、D21、D28:P < .001)。
- 小胶质细胞溶酶体内Gephyrin斑点体积增大(t = -23.273,P < .001;t = -27.997,P < .001)。
- 米诺环素或S-氯胺酮治疗产生镇痛和抗吞噬效应(多项t检验P < .001)。
临床怎么用
- 该机制提示小胶质细胞突触吞噬可能成为骨癌痛干预的潜在靶点。
- 米诺环素和S-氯胺酮在模型中显示镇痛及抗吞噬作用,但尚需临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The microglial activation has been implicated in cancer-induced bone pain. Recent studies have revealed that microglia mediate synaptic pruning in the central nervous system, where the cluster of differentiation 47-signal regulatory protein α (CD47-SIRPα) axis creates a "don't eat me" signal and elicits an antiphagocytic effect to protect synapses against elimination. To date, the synaptic phagocytosis in microglia has never been investigated in the murine cancer-induced bone pain model. The present experiments sought to explore whether microglia phagocytize synapses in mice with bone cancer pain as well as the possible mechanisms. METHODS: Male C3H/HeN mice were used to induce bone cancer pain. Minocycline and S-ketamine were injected into D14. The number of spontaneous flinches (NSF) and paw withdrawal mechanical thresholds (PWMT) were measured on D0, D4, D7, D10, D14, D21, and D28. Hematoxylin and eosin staining presented bone lesions. Western blotting examined the Gephyrin, CD47, and SIRPα expression. Flow cytometry evaluated the proportion of SIRPα + cells in the spine. Immunofluorescence and 3-dimensional reconstruction showed the Gephyrin puncta inside microglial lysosomes. RESULTS: Mice embedded with tumor cells induced persistent spontaneous pain and mechanical hyperalgesia. Hematoxylin and eosin staining revealed bone destruction and tumor infiltration in marrow cavities. Microglia underwent a responsive and proliferative burst (t = -16.831, P < .001). Western blotting manifested lowered Gephyrin expression in the tumor group (D4, D7, D10, D14, D21, and D28: P < .001). Immunofluorescence and 3-dimensional reconstruction showed larger volumes of Gephyrin puncta inside microglial lysosomes (t = -23.273, P < .001; t = -27.997, P < .001). Treatment with minocycline or S-ketamine exhibited pain relief and antiphagocytic effects (t = -6.191, P < .001, t = -7.083, P < .001; t = -20.767, P < .001, t = -17.080, P < .001; t = 11.789, P < .001, t = 16.777, P < .001; t = 8.868, P < .001, t = 21.319, P < .001). Last but not least, the levels of CD47 and SIRPα proteins were downregulated (D10: P = .004, D14, D21, and D28: P < .001; D10, D14, D21, and D28: P < .001). Flow cytometry and immunofluorescence substantiated reduced microglial SIRPα (t = 11.311, P < .001; t = 12.189, P < .001). CONCLUSIONS: Microglia-mediated GABAergic synapse pruning in the spinal cord dorsal horn in bone cancer pain mice, which might be associated with the declined CD47-SIRPα signal. Our research uncovered an innovative mechanism that highlighted microglia-mediated synaptic phagocytosis in a murine cancer-induced bone pain model.
引用
- Zhang Z, Mao Y, Huang S, et al. Microglia Promote Inhibitory Synapse Phagocytosis in the Spinal Cord Dorsal Horn and Modulate Pain-Like Behaviors in a Murine Cancer-Induced Bone Pain Model. Anesth Analg. 2024. PMID: 38241681. doi:10.1213/ANE.0000000000006824
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。